| 1. |
Specchio N, Wirrell EC, Scheffer IE, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia, 2022, 63(6): 1398-1442.
|
| 2. |
Wirrell EC, Hamiwka L, Farrell K, et al. Neuropsychological outcomes in children with self-limited epilepsy with centrotemporal spikes: a systematic review and meta-analysis. Epilepsia, 2020, 61(11): 2327-2340.
|
| 3. |
Kessi M, Yan F, Pan L, et al. Treatment for the benign childhood epilepsy with centrotemporal spikes: a monocentric study. Front Neurol, 2021, 12: 670958.
|
| 4. |
Camfield P, Camfield C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia, 2007, 48(6): 1128-1132.
|
| 5. |
Hakami T. Neuropharmacology of antiseizure drugs. Neuropsychopharmacol Rep, 2021, 41(3): 336-351.
|
| 6. |
朱冰封. 不同劑量丙戊酸鈉分別聯合左乙拉西坦對癲癇患兒腦電活動和認知功能的影響比較. 臨床合理用藥雜志, 2025, 18(5): 129-132.
|
| 7. |
武晨, 江文. 突觸囊泡蛋白2A: 抗癲癇藥物的新靶點. 國際神經病學神經外科學雜志, 2014, 41(3): 260-264.
|
| 8. |
de Weerd AW, Aldenkamp AP, Alpherts WC, et al. Cognitive and behavioral comorbidities in children with self-limited epilepsy with centrotemporal spikes: A cross-sectional study. Epilepsy Behav, 2022, 134: 108264.
|
| 9. |
Paolicchi JM, Loddenkemper T, Chu-Shore CJ, et al. Frontal lobe epileptiform discharges in self-limited epilepsy with centrotemporal spikes: association with attention and executive function. Dev Med Child Neurol, 2023, 65(3): 321-328.
|